These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 4976942)

  • 1. The clinical use of nalidixic acid. A review and some observations.
    Stamey TA; Nemoy NJ; Higgins M
    Invest Urol; 1969 May; 6(6):582-92. PubMed ID: 4976942
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nalidixic acid].
    Pagnini G
    Antibiotica; 1967 Jun; 5(2):134-59. PubMed ID: 4389549
    [No Abstract]   [Full Text] [Related]  

  • 3. Nalidixic acid in urinary infection.
    Neogy KN; De MS; Chatterjee ML
    Bull Calcutta Sch Trop Med; 1968 Jan; 16(1):11-2. PubMed ID: 4890385
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies with nitrofurantoin: bacteriological studies with microorganisms causing urinary tract infections].
    Hein H
    Arzneimittelforschung; 1969 Sep; 19(9):1579-84. PubMed ID: 4981210
    [No Abstract]   [Full Text] [Related]  

  • 5. Antimicrobial sensitivity patterns as a guide to the domiciliary treatment of urinary tract infections.
    Harvey KJ; Smith DD
    Med J Aust; 1972 Jan; 1(4):177-8. PubMed ID: 4551815
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study of nalidixic acid activity on 3186 strains of Gram negative bacilli. Application to the treatment of urinary infections].
    Chamfeuil R; Curcier H
    Presse Med (1893); 1969 Nov; 77(48):1763-4. PubMed ID: 4903534
    [No Abstract]   [Full Text] [Related]  

  • 7. [Nalidixic acid (Neggram) in the treatment of chronic non-specific urinary tract infections].
    Porpáczy P; Haschek H; Zischka-Konorsa W; Hermanek P; Bibus B
    Wien Klin Wochenschr; 1968 Feb; 80(5):87-93. PubMed ID: 5667719
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the antibacterial activity of nalidixic acid].
    Ambrosoli G; Ciarlini E; Lanzarini GF; Taverna L
    Ig Mod; 1965; 58(11):935-45. PubMed ID: 4965236
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical evaluation of antimicrobial agents in urinary tract infections (urinary tract infections in paraplegics. II)].
    Kondo M
    Hinyokika Kiyo; 1967 Jul; 13(7):567-73. PubMed ID: 4868521
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of urinary tract infections with cephalexin an oral antibiotic of cephalosporin-group].
    Hofmeister H; Scharrer G; Sawallisch R
    Arzneimittelforschung; 1970 Jan; 20(1):139-42. PubMed ID: 4986282
    [No Abstract]   [Full Text] [Related]  

  • 11. Sulphadimidine and nalidixic acid therapy in urinary-tract infections in general practice.
    Brown PC; Donaghy MC; Dootson PH; Titcombe DH; MacLaren DM
    Practitioner; 1971 Dec; 207(242):819-26. PubMed ID: 4947233
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical evaluation of cefazedon on patients with urinary tract infections (author's transl)].
    Lenzner A; Koch E
    Med Klin; 1979 May; 74(21):834-8. PubMed ID: 112365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hospitalism in urology].
    Lipsky H
    Med Klin; 1970 Oct; 65(42):1833-8. PubMed ID: 4997048
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy results with nalidixic acid in chronic urinary tract infection].
    Broghammer H
    Arzneimittelforschung; 1968 Sep; 18(9):1139-43. PubMed ID: 4885373
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current status of drug-resistant bacteria and the treatment of refractory infections].
    Matsuda S
    Sanfujinka No Jissai; 1970 Feb; 19(2):182-91. PubMed ID: 4909406
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drug-resistant organisms in urinary tract infections and clinical use of Wintomylon (nalidixic acid)].
    Kuze M; Kashiwagi T; Okita J; Komiya T; Nihira H
    Hinyokika Kiyo; 1966 Mar; 12(3):291-6. PubMed ID: 6006673
    [No Abstract]   [Full Text] [Related]  

  • 17. Nalidixic acid and oxolinic acid in the treatment of chronic bacteriuria.
    Atlas E; Clark H; Silverblatt F; Turck M
    Ann Intern Med; 1969 Apr; 70(4):713-21. PubMed ID: 4977045
    [No Abstract]   [Full Text] [Related]  

  • 18. [Nalidixic acid (Wintomylon) and bacterial resistance to antibiotics in urinary tract infections].
    Makino M
    Hinyokika Kiyo; 1968 Jun; 14(6):351-6. PubMed ID: 4882490
    [No Abstract]   [Full Text] [Related]  

  • 19. Observations on the clinical use of nalidixic acid.
    Stamey TA
    Postgrad Med J; 1971 Sep; 47():Suppl:21-6. PubMed ID: 5112308
    [No Abstract]   [Full Text] [Related]  

  • 20. A critical evaluation of nalidixic acid in urinary-tract infections.
    Ronald AR; Turck M; Petersdorf RG
    N Engl J Med; 1966 Nov; 275(20):1081-9. PubMed ID: 5923022
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.